Abstract
The US Preventive Services Task Force (USPSTF), with no urology representative, reviewed what it considered the relevant published data and concluded that available evidence is insufficient to assess the balance between potential benefits and harms of using PSA to screen men aged < 75 years old for prostate cancer and has recommended against screening men aged > 75 years old (even those at high risk). 1 U.S. Preventive Services Task ForceScreening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008; 149: 185-191 Crossref PubMed Scopus (484) Google Scholar Public Survey and Survival Data Do Not Support Recommendations to Discontinue Prostate-specific Antigen Screening in Men at Age 75UrologyVol. 75Issue 5PreviewTo evaluate the US Preventative Services Task Force (USPSTF) recommendation to discontinue prostate-specific antigen (PSA) screening at age 75. Full-Text PDF ReplyUrologyVol. 75Issue 5PreviewWe sincerely appreciate Dr Catalona's Editorial Comment regarding our article and agree completely with his comments. Over the last year, prostate cancer seems to have been the “whipping boy” of the press. In August 2008, as Dr Catalona notes, the USPSTF recommended against PSA testing in men aged ≥75 years. This was front-page news in USA Today and other papers as it hinted of health care rationing and age discrimination. In the spring of 2009, the press had a field day with the ERSPC and PLCO trial results, generally headlining that screening is not beneficial and ignoring the positive findings from the ERSPC study that showed a 20% reduction in mortality and a 41% reduction in metastatic disease rates in screened men. Full-Text PDF
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
